Announcement • May 27
Talon Resources plc has filed a Follow-on Equity Offering in the amount of £2 million. Talon Resources plc has filed a Follow-on Equity Offering in the amount of £2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 160,000,000
Price\Range: £0.0125 Announcement • May 18
Talon Resources plc Requests Cancellation of Listing of Ordinary Shares from London Stock Exchange Talon Resources plc ("Talon" or the "Company") announced that it has requested the Financial Conduct Authority (FCA) to cancel the listing of its ordinary shares of £0.01 each (the "Shares") from the Equity Shares (Shell Companies) category of the Official List and to request the London Stock Exchange to cancel the admission to trading of the Shares on its Main Market for listed securities (together, the "Cancellation"). The Company further announces that it intends to apply for the admission of the Shares to trading on AIM ("Admission"). It is expected that Cancellation and Admission will occur simultaneously. In accordance with Listing Rule 5.2.8, the Company is required to give at least 20 business days' notice of the intended Cancellation. Accordingly, it is expected that the Cancellation will become effective from 8.00 a.m. on June 16, 2026, with the last day of trading of the Shares on the Main Market being June 15, 2026. The Directors believe that AIM represents a more appropriate market for the Company given the size and stage of development, offering a more flexible regulatory environment, particularly in relation to corporate transactions, and access to a broader pool of institutional and other investors. Admission is expected to become effective, and dealings in the Shares are expected to commence on AIM, at 8.00 a.m. on June 16, 2026. Announcement • Mar 25
Medcaw Investments Plc announced that it has received £0.024 million in funding Medcaw Investments Plc announced a private placement to issue unsecured Convertible Loan Notes for the proceeds of £24,000 on March 25, 2026. The conversion price is £0.01. In addition, the CLN holder will, upon conversion, be granted warrants to subscribe for one new ordinary share for every two shares received on conversion. The warrants will carry an exercise price of £0.03 per share and will be exercisable for a period of 12 months from the date of grant. 
